AMANDA TECSON: Open Payments
NPI 1558783019 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 21 payments from 13 companies in 2025. Trend: 2023 $1,778 · 2024 $1,818 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $83 |
| TerSera Therapeutics LLC | 2 | $71 |
| Rigel Pharmaceuticals, Inc. | 3 | $61 |
| ARRAY BIOPHARMA INC | 2 | $50 |
| ABBVIE INC. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Genentech USA, Inc. | 1 | $26 |
| Celgene Corporation | 1 | $22 |
Products named: KEYTRUDA, Xermelo, TAVALISSE, LORBRENA, VENCLEXTA, TALVEY, OPDIVO, LUTATHERA.
Industry payments across IN — which companies pay providers there.
